Abstract:By using the prominent merit of poly( N -isopropylacrylamide) (PNIPAm) that can reversibly switch from a linear state to a coiled state with the change in temperature, in this work, gelatin was grafted with carboxylic end-capped PNIPAm as the matrix material to fabricate a physical entanglement crosslinked hydrogel microneedles (MNs) patch that can control drug release after application on the skin. The crystallization of the drug during the fabrication process of MNs was decreased due to the thermo-reversible sol-gel transition of the matrix materials. In addition, to increase the mechanical strength of the MNs and to decrease the application time, the gelatin-g-PNIPAm (GP) MNs patch was mounted onto solid MNs to fabricate a rapidly separating MNs system (RS-GP-MNs). The combination of the rapidly separating technique and the thermosensitive hydrogel provides the combined ability to efficiently deliver drug-loaded MNs into the skin within few seconds and to control drug release within the skin. Through a series of tests, we found that RS-GP-MNs showed suitable lower critical solution temperature and adequate crosslinking speed for practical application. The hypoglycemic effect in diabetic mice was characteristically controlled by insulin release through RS-GP-MNs as compared to the MNs made from unmodified gelatin. The proposed RS-GP-MNs system is potentially applicable to various hydrophilic small molecular and peptide medicines that require frequent dosing, thus providing an effective, noninvasive, and painless administration method with minimal safety concerns. Statement of Significance 1. Hydrogel microneedles that can be reversibly triggered and controllably release drugs at body temperature were fabricated. 2. Hydrogel microneedles prepared from gelatin-g-PNIPAm can avoid the use of a molecular crosslinker that is toxic and difficult to be completely removed. 3. Gelatin-g-PNIPAm with thermosensitive property showed appropriate molecular interactions with the drug and slowed down the crystallization speed of the drug in the solution.

Silk fibroin/chitosan pH-sensitive controlled microneedles

Insulin-Loaded Silk Fibroin Microneedles As Sustained Release System

Glucose-Responsive Silk Fibroin Microneedles for Transdermal Delivery of Insulin

Electro-responsive Silk Fibroin Microneedles for Controlled Release of Insulin

Development of glucose/pH responsive smart hydrogel of carbopol and application in microneedles

Combined Silk Fibroin Microneedles for Insulin Delivery

Swellable Silk Fibroin Microneedles for Transdermal Drug Delivery.

Sustained release of insulin from silk microneedles

Intelligent Microneedle Patch Based on Functionalized Alginate and Chitosan for Long-Term Self-Regulated Insulin Delivery

Facile Fabrication of Silk Fibroin/Off-Stoichiometry Thiol-Ene (OSTE) Microneedle Array Patches

Bioresponsive Microneedles with a Sheath Structure for H2 O2 and Ph Cascade-Triggered Insulin Delivery.

Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery

Highly Porous Silk Fibroin Scaffold Packed in PEGDA/Sucrose Microneedles for Controllable Transdermal Drug Delivery

Reinforcement of Silk Microneedle Patches for Accurate Transdermal Delivery

Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin.

Thermosensitive hydrogel microneedles for controlled transdermal drug delivery

Silk Fibroin Microneedles for Transdermal Drug Delivery: Where Do We Stand and How Far Can We Proceed?

Polymer microneedles integrated with glucose-responsive mesoporous bioactive glass nanoparticles for transdermal delivery of insulin

Cross-Linking-Density-Changeable Microneedle Patch Prepared from a Glucose-Responsive Hydrogel for Insulin Delivery

Advanced Silk Fibroin Biomaterials‐Based Microneedles for Healthcare

Silk/polyols/GOD Microneedle Based Electrochemical Biosensor for Continuous Glucose Monitoring.